Intelligence Dashboards

Search and filter 146,000+ clinical trials by drug, sponsor, phase, and condition.

10 years of FDA novel drug approvals (2016-2025) with designation data: first-in-class, orphan drug, breakthrough therapy, and more.

Upcoming FDA target action dates. Know when approval decisions are expected.

Track Phase 1-4 trial activity by company. See who has the strongest clinical pipeline.

Deep dive into any company's trial portfolio by therapeutic area and phase.

See who's competing in each indication. Trial counts, sponsors, and phase breakdown.

Rising and falling indications based on trial activity over time.

FDA-approved biosimilars, reference products, and market leaders.

Blockbuster drugs losing exclusivity 2026–2032. Actual company revenue from SEC filings. Patent dates from Orange Book + manual overrides.

CMS Medicare Part D spending for drugs losing exclusivity 2026–2030. Historical cliff case studies.

Trial activity and competition by indication. Identify concentrated vs fragmented markets.

Competitive density heatmap across all therapeutic areas.

Head-to-head comparison of any two company portfolios.

Browse the indication taxonomy and see coverage metrics.